Total Payments
$334.35
2024 Payments
$159.01
Companies
8
Transactions
18
Medicare Patients
2,621
Medicare Billing
$260,679
Payment Breakdown by Category
Food & Beverage$334.35 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $334.35 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $87.56 | 6 | $0 (2019) |
| HARMONY BIOSCIENCES LLC | $56.49 | 3 | $0 (2024) |
| Fisher & Paykel Healthcare Inc | $49.83 | 2 | $0 (2024) |
| INOGEN, INC. | $37.95 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $32.28 | 2 | $0 (2023) |
| Mylan Specialty L.P. | $28.80 | 1 | $0 (2024) |
| Amgen Inc. | $24.44 | 1 | $0 (2024) |
| Philips Electronics North America Corporation | $17.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159.01 | 7 | Fisher & Paykel Healthcare Inc ($49.83) |
| 2023 | $52.92 | 3 | Harmony Biosciences LLC ($19.30) |
| 2022 | $17.00 | 1 | Philips Electronics North America Corporation ($17.00) |
| 2021 | $17.86 | 1 | GlaxoSmithKline, LLC. ($17.86) |
| 2019 | $25.75 | 2 | Allergan Inc. ($25.75) |
| 2018 | $13.14 | 1 | Allergan Inc. ($13.14) |
| 2017 | $48.67 | 3 | Allergan Inc. ($48.67) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 07/31/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: Narcoplepsy | ||||||
| 07/08/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: Narcoplepsy | ||||||
| 05/15/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Sleep | ||||||
| 03/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/23/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Sleep | ||||||
| 02/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Inflammation | ||||||
| 12/11/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: SLEEP MEDICINE | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | Inogen, Inc. | INOGEN (Device) | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 04/21/2022 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Medical Device | ||||||
| 02/16/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2019 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 01/18/2019 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/29/2018 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 12/11/2017 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 05/02/2017 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 02/24/2017 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: CYSTIC FIBROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 791 | 924 | $134,998 | $56,952 |
| 2022 | 8 | 751 | 858 | $135,982 | $63,765 |
| 2021 | 10 | 752 | 950 | $191,504 | $80,570 |
| 2020 | 6 | 327 | 478 | $134,057 | $59,391 |
Total Patients
2,621
Total Services
3,210
Medicare Billing
$260,679
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 177 | 273 | $66,069 | $34,312 | 51.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $16,323 | $7,435 | 45.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 39 | 46 | $10,166 | $4,265 | 42.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 19 | $7,695 | $3,038 | 39.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $4,147 | $1,624 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 16 | $2,790 | $1,554 | 55.7% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 72 | 79 | $4,503 | $1,327 | 29.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 133 | 140 | $15,400 | $1,081 | 7.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 114 | 116 | $3,480 | $1,030 | 29.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 129 | 135 | $2,295 | $897.00 | 39.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 27 | 27 | $810.00 | $250.56 | 30.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 12 | 12 | $1,320 | $137.36 | 10.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 146 | 207 | $45,747 | $27,253 | 59.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 84 | 122 | $26,929 | $13,118 | 48.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 64 | 64 | $20,400 | $8,727 | 42.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 48 | 48 | $15,312 | $7,994 | 52.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 45 | 48 | $7,584 | $2,803 | 37.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 86 | 88 | $2,640 | $833.32 | 31.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 13 | 13 | $2,054 | $657.88 | 32.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 34 | 34 | $1,938 | $604.76 | 31.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 83 | 85 | $1,445 | $598.15 | 41.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 65 | 65 | $7,150 | $525.38 | 7.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 19 | 19 | $570.00 | $181.42 | 31.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 25 | 26 | $1,690 | $170.33 | 10.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 20 | 20 | $2,200 | $163.51 | 7.4% |
About Dr. Steven Strausbaugh, MD
Dr. Steven Strausbaugh, MD is a Pulmonary Disease healthcare provider based in Geneva, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427070838.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Strausbaugh, MD has received a total of $334.35 in payments from pharmaceutical and medical device companies, with $159.01 received in 2024. These payments were reported across 18 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($334.35).
As a Medicare-enrolled provider, Strausbaugh has provided services to 2,621 Medicare beneficiaries, totaling 3,210 services with total Medicare billing of $260,679. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pediatric Pulmonology
- Location Geneva, OH
- Active Since 07/24/2006
- Last Updated 12/01/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1427070838
Products in Payments
- ZENPEP (Drug) $87.56
- WAKIX (Drug) $56.49
- FISHER & PAYKEL HEALTHCARE (Device) $49.83
- NUCALA (Biological) $32.28
- YUPELRI (Drug) $28.80
- TEZSPIRE (Biological) $24.44
- INOGEN (Device) $19.20
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $18.75
- (8874) inCourage (Device) $17.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.